The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
Abstract
The development of small‐molecule modulators of protein–protein interactions is a formidable goal, albeit one that possesses significant potential for the discovery of novel therapeutics. Despite the daunting challenges, a variety of examples exists for the inhibition of two large protein partners with low‐molecular‐weight ligands. This review discusses the strategies for targeting protein–protein interactions and the state of the art in the rational design of molecules that mimic the structures and functions of their natural targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–296 of 296
Blaskovich, M. A., Lin, Q., Delarue, F. L., Sun, J., Park, H. S., Coppola, D., Hamilton, A. D., & Sebti, S. M. (2000) · Nature Biotechnology · doi:10.1038/80257 · Cited by 143
Self-citationAviezer, D., Cotton, S., David, M., Segev, A., Khaselev, N., Galili, N., Gross, Z., & Yayon, A. (2000) · PubMed · Cited by 143
Kato‐Stankiewicz, J., Hakimi, I., Zhi, G., Zhang, J., Serebriiskii, I. G., Guo, L., Edamatsu, H., Koide, H., Menon, S., Eckl, R. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222222699 · Cited by 143
The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis
Takimoto, R., Wang, W., Dicker, D. T., Rastinejad, F., Lyssikatos, J. P., & El‐Deiry, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.41 · Cited by 142
Springer, B. A., Pantoliano, M. W., Barbera, F. A., Gunyuzlu, P. L., Thompson, L. D., Herblin, W. F., Rosenfeld, S. A., & Book, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47101-3 · Cited by 141
A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1
Vincenti, F. G., Lantz, M. V., Birnbaum, J. L., Garovoy, M. R., Mould, D. R., Hakimi, J., Nieforth, K. A., & Light, S. E. (1997) · Transplantation · doi:10.1097/00007890-199701150-00007 · Cited by 141
Yin, H. H., Lee, G.-I., Sedey, K. A., Rodriguez, J. M., Wang, H., Sebti, S. M., & Hamilton, A. D. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0446404 · Cited by 141
Self-citationHarrison, S. C., Ferrer, M., Kapoor, T. M., Strassmaier, T., Weissenhorn, W., Skehel, J. J., Oprian, D., Schreiber, S. L., & Wiley, D. C. (1999) · Nature Structural Biology · doi:10.1038/13324 · Cited by 139
Cutting Edge: A Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion
Kelly, T. A., Jeanfavre, D. D., McNeil, D. W., Woska, J. R., Reilly, P. L., Mainolfi, E. A., Kishimoto, K. M., Nabozny, G. H., X.-J.Zinter, R. W., Bormann, B., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5173 · Cited by 139
Tian, S., Tapley, P., Sincich, C., Stein, R., Rosen, J., & Lamb, P. (1996) · Blood · doi:10.1182/blood.v88.12.4435.bloodjournal88124435 · Cited by 136
Smith, A. B., Keenan, T. P., Holcomb, R. C., Sprengeler, P. A., Guzman, M. C., Wood, J. L., Carroll, P. J., & Hirschmann, R. F. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00052a093 · Cited by 136
Bartfai, T., Behrens, M. M., Gaidarova, S., Pemberton, J., Shivanyuk, A. N., & REBEK, J. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932746100 · Cited by 135
Last-Barney, K., Davidson, W. C., Cardozo, M. G., Frye, L. L., Grygon, C. A., Hopkins, J. L., Jeanfavre, D. D., Pav, S., Qian, C., Stevenson, J. M., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0104249 · Cited by 132
Takano, S., Gately, S. T., Neville, M. E., Herblin, W. F., Gross, J. L., Engelhard, H. H., Perricone, M. A., Eidsvoog, K., & Brem, S. S. (1994) · PubMed · Cited by 131
Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129
Highly Specific DNA Recognition by a Designed Miniature Protein
Zondlo, N. J., & Schepartz, A. (1999) · Journal of the American Chemical Society · doi:10.1021/ja990968z · Cited by 129
Wang, W., Takimoto, R., Rastinejad, F., & El-Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2171-2181.2003 · Cited by 126
Peptide Toxins and Potassium Channels
Dreyer, F. (1990) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/978-3-662-41884-0_3 · Cited by 125
Small molecule antagonists of proteins
Gadek, T. R., & Nicholas, J. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01479-x · Cited by 120
Lugovskoy, A. A., Degterev, A., Fahmy, A. F., Zhou, P., Gross, J. D., Yuan, J., & Wagner, G. (2002) · Journal of the American Chemical Society · doi:10.1021/ja011239y · Cited by 120
Hirschmann, R. F., Hynes, J. J., Cichy-Knight, M. A., van Rijn, R. D., Sprengeler, P. A., Spoors, P. G., Shakespeare, W. C., Pietranico‐Cole, S. L., Barbosa, J., Liu, J., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800346 · Cited by 117
Design and Evolution of a Miniature Bcl-2 Binding Protein
Chin, J. W., & Schepartz, A. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20011015)40:20<3806::aid-anie3806>3.0.co;2-b · Cited by 112
Protein functional epitopes: hot spots, dynamics and combinatorial libraries
Ma, B., Wolfson, H. J., & Nussinov, R. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00216-5 · Cited by 111
A systematic method for identifying small-molecule modulators of protein–protein interactions
Horswill, A. R., Savinov, S. N., & Benkovic, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406999101 · Cited by 110
Williams, W. V., Kieber‐Emmons, T., VonFeldt, J. M., Greene, M. I., & Weiner, D. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67772-0 · Cited by 109
Protein–protein interactions: mechanisms and modification by drugs
Veselovsky, A. V., Ivanov, Y. D., Ivanov, A. S., Archakov, A. I., Lewi, P. J., & Janssen, P. (2002) · Journal of Molecular Recognition · doi:10.1002/jmr.597 · Cited by 105
Vuister, G. W., Kim, S. J., Wu, C. C. M., & Bax, A. (1994) · Biochemistry · doi:10.1021/bi00167a002 · Cited by 104
Mimicry of erythropoietin by a nonpeptide molecule
Qureshi, S. A., Kim, R. M., Konteatis, Z. D., Biazzo-Ashnault, D. E., Motamedi, H., Rodrigues, R., Boice, J. A., Calaycay, J. R., Bednarek, M. A., Griffin, P. R., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12156 · Cited by 102
Blasko, E., Glaser, C. B., Devlin, J. J., Xia, W., Feldman, R. I., Polokoff, M. A., Phillips, G. B., Whitlow, M. D., Auld, D. S., McMillan, K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105691200 · Cited by 101
Sauvé, K., Nachman-Clewner, M., Spence, C. L., Bailon, P., Campbell, E., Tsien, W. H., Kondas, J. A., Hakimi, J., & Ju, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4636 · Cited by 100
Reversible “Irreversible” Inhibition of Chymotrypsin Using Nanoparticle Receptors
Fischer, N. O., Verma, A., Goodman, C. M., Simard, J. M., & Rotello, V. M. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0352505 · Cited by 99
A Two-hybrid Dual Bait System to Discriminate Specificity of Protein Interactions
Serebriiskii, I. G., Khazak, V., & Golemis, E. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17080 · Cited by 98
Surface Recognition of a Protein Using Designed Transition Metal Complexes
Fazal, M. A., Roy, B. C., Sun, S., Mallik, S., & Rodgers, K. R. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003193z · Cited by 98
Dall’Acqua, W. F., & Carter, P. M. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80121-8 · Cited by 96
Molecular Recognition of Protein Surfaces: High Affinity Ligands for the CBP KIX Domain
Rutledge, S. E., Volkman, H. M., & Schepartz, A. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034508o · Cited by 94
Designing Small-Molecule Switches for Protein-Protein Interactions
Guo, Z., Zhou, D., & Schultz, P. G. (2000) · Science · doi:10.1126/science.288.5473.2042 · Cited by 93
Soga, S., Kozawa, T., Narumi, H., Akinaga, S., Irie, K., Matsumoto, K., Sharma, S. V., Nakano, H., Mizukami, T., & Hara, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.822 · Cited by 93
Ligand Binding Energy and Catalytic Efficiency from Improved Packing within Receptors and Enzymes
Williams, D. H., Stephens, E., & Zhou, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00428-5 · Cited by 91
Bar‐Sagi, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1441-1443.2001 · Cited by 89
Tendamistat as a Scaffold for Conformationally Constrained Phage Peptide Libraries
McConnell, S. J., & Hoess, R. H. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0390 · Cited by 86
Waldmann, H., Karaguni, I., Carpintero, M., Gourzoulidou, E., Herrmann, C., Brockmann, C., Oschkinat, H., & Müller, O. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353089 · Cited by 83
Welzenbach, K., Hommel, U., & Weitz‐Schmidt, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110521200 · Cited by 82
Peptide toxins and potassium channels
Dreyer, F. (1990) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0033953 · Cited by 81
Ubiquitous Induction of p53 in Tumor Cells by Antisense Inhibition of MDM2 Expression
Chen, L., Lu, W., Agrawal, S., Zhou, W., Zhang, R., & Chen, J. (1999) · Molecular Medicine · doi:10.1007/bf03402136 · Cited by 79
The role of the cleavage site 2′-hydroxyl in the Tetrahymena group I ribozyme reaction
Yoshida, A., Shan, S., Herschlag, D., & Piccirilli, J. A. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00074-0 · Cited by 78
NGF ligand alters NGF signaling via p75NTR and TrkA
Niederhauser, O., Mangold, M., Schubenel, R., Kusznir, E.-A., Schmidt, D., & Hertel, C. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000801)61:3<263::aid-jnr4>3.0.co;2-m · Cited by 77
Kenny, C. H., Ding, W., Kelleher, K. S., Benard, S., Dushin, E. G., Sutherland, A. G., Mosyak, L., Kriz, R., & Ellestad, G. A. (2003) · Analytical Biochemistry · doi:10.1016/j.ab.2003.08.033 · Cited by 76
Alternate protein frameworks for molecular recognition.
Ku, J., & Schultz, P. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6552 · Cited by 74
Huang, C., & Springer, T. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3162 · Cited by 73
Automated multiple structure alignment and detection of a common substructural motif
Leibowitz, N., Fligelman, Z. Y., Nussinov, R., & Wolfson, H. J. (2001) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.1034 · Cited by 73
Selective disruption of protein aggregation by cyclodextrin dimers
Leung, D. K.-W., Yang, Z., & Breslow, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5050 · Cited by 72
Identification of Potent Ras Signaling Inhibitors by Pathway‐Selective Phenotype‐Based Screening
Müller, O., Gourzoulidou, E., Carpintero, M., Karaguni, I., Langerak, A., Herrmann, C., Möröy, T., Klein‐Hitpaß, L., & Waldmann, H. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200352587 · Cited by 71
Design, Synthesis and Biological Evaluation of Carbohydrate-Based Mimetics of cRGDFV
Nicolaou, K. C., Trujillo, J. I., & Chibale, K. (1997) · Tetrahedron · doi:10.1016/s0040-4020(97)00567-x · Cited by 71
Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein
Yin, H. H., & Hamilton, A. D. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.096 · Cited by 69
Self-citationSweet, R. W., Truneh, A., & Hendrickson, W. A. (1991) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(91)90089-n · Cited by 68
Designing DNA-binding proteins on the surface of filamentous phage
Choo, Y., & Klug, A. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80073-5 · Cited by 68
Li, L.-Y., Safran, M., Aviezer, D., Boehlen, P., Seddon, A. P., & Yayon, A. (1994) · Biochemistry · doi:10.1021/bi00202a020 · Cited by 68
Changing the Structural Context of a Functional β-Hairpin
Drakopoulou, E., Zinn‐Justin, S., Guenneugues, M., Gilquin, B., Ménèz, A., & Vita, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11979 · Cited by 68
Blaydes, J. P., Gire, V., Rowson, J., & Wynford‐Thomas, D. (1997) · Oncogene · doi:10.1038/sj.onc.1201018 · Cited by 67
Terphenyl‐Based Helical Mimetics That Disrupt the p53/HDM2 Interaction
Yin, H. H., Lee, G., Park, H. S., Payne, G. A., Rodriguez, J. M., Sebti, S. M., & Hamilton, A. D. (2005) · Angewandte Chemie · doi:10.1002/ange.200462316 · Cited by 67
Self-citationThe affinity‐selection of a minibody polypeptide inhibitor of human interleukin‐6.
Martin, F., Toniatti, C., Salvati, A. L., Venturini, S., Ciliberto, G., Cortese, R., & Sollazzo, M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06864.x · Cited by 65
Song, L., Gao, J., Satoh, T. K., Friedman, T. M., Edling, A. E., Koch, U., Choksi, S., Han, X., Korngold, R., & Huang, Z. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.73 · Cited by 64
Smith, A. B., Hirschmann, R. F., Pasternak, A., Yao, W., Sprengeler, P. A., Holloway, M. K., Kuo, L. C., Chen, Z., Darke, P. L., & Schleif, W. A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970195u · Cited by 63
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
Gerbitz, A., Mautner, J., Geltinger, C., Hörtnagel, K., Christoph, B., Asenbauer, H., Klobeck, G., Polack, A., & Bornkamm, G. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202468 · Cited by 60
Winn, M., Reilly, E. B., Liu, G., Huth, J. R., Jae, H.-S., Freeman, J. C., Pei, Z., Xin, Z., Lynch, J., Kester, J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0103108 · Cited by 58
Design of growth factor antagonists with antiangiogenic and antitumor properties
Sebti, S. M., & Hamilton, A. D. (2000) · Oncogene · doi:10.1038/sj.onc.1204121 · Cited by 58
Self-citationWei, Y., McLendon, G. L., Case, M. A., Purring-Koch, C., Yu, T., Hamilton, A. D., Lin, Q., Park, H. S., & Lee, C.-S. (2001) · Chemical Communications · doi:10.1039/b104142h · Cited by 58
Self-citationDesign and synthesis of type-III mimetics of ω-conotoxin GVIA
Baell, J. B., Forsyth, S. A., Gable, R. W., Norton, R. S., & Mulder, R. J. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1015930031890 · Cited by 57
Small Molecule Ligands Define a Binding Site on the Immune Regulatory Protein B7.1
Erbe, D. V., Wang, S., Xing, Y., & Tobin, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110162200 · Cited by 57
Solution Structure of ZipA, a Crucial Component ofEscherichia coliCell Division
Moy, F. J., Glasfeld, E., Mosyak, L., & Powers, R. (2000) · Biochemistry · doi:10.1021/bi0009690 · Cited by 56
Winter, G. P., & Harris, W. J. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90197-r · Cited by 56
Structure-based design of carboxybiphenylindole inhibitors of the ZipA–FtsZ interaction
Sutherland, A. G., Alvarez, J., Ding, W., Foreman, K. W., Kenny, C. H., Labthavikul, P., Mosyak, L., Petersen, P. J., Rush, T. S., Ruzin, A. V., et al. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b312016c · Cited by 54
Martin, F., Toniatti, C., Salvati, A. L., Ciliberto, G., Cortese, R., & Sollazzo, M. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0008 · Cited by 52
Emerson, S. D., Palermo, R. E., Liu, C., Tilley, J., Chen, L., Danho, W., Madison, V., Greeley, D. N., Ju, G., & Fry, D. C. (2003) · Protein Science · doi:10.1110/ps.0232803 · Cited by 51
Kahle, P. J., Barker, P. A., Shooter, E. M., & Hertel, C. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380512 · Cited by 48
Fasan, R., Dias, R. L. A., Moehle, K., Zerbe, O., Vrijbloed, J. W., Obrecht, D., & Robinson, J. A. (2004) · Angewandte Chemie · doi:10.1002/ange.200353242 · Cited by 48
Green, N. J., Xiang, J. S., Chen, J., Chen, L.-R., Davies, A. M., Erbe, D., Tam, S., & Tobin, J. F. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00183-4 · Cited by 47
Stoichiometry, Free Energy, and Kinetic Aspects of Cytochromec: Apaf-1 Binding in Apoptosis
Purring, C. B., Zou, H., Wang, X., et al. (1999) · Journal of the American Chemical Society · doi:10.1021/ja991235h · Cited by 46
The new sulindac derivative IND 12 reverses Ras-induced cell transformation.
Karaguni, I., Herter, P., Debruyne, P. R., Chtarbova, S., Kasprzynski, A., Herbrand, U., Ahmadian, M.-R., Glüsenkamp, K., Winde, G., Mareel, M. M. K., et al. (2002) · PubMed · Cited by 45
Calorimetric studies on the interaction of horse ferricytochrome c and yeast cytochrome c peroxidase
Kresheck, G. C., Vitello, L. B., & Erman, J. E. (1995) · Biochemistry · doi:10.1021/bi00026a022 · Cited by 45
Modulation von Protein‐Protein‐Wechselwirkungen mit niedermolekularen organischen Molekülen
Berg, T. (2003) · Angewandte Chemie · doi:10.1002/ange.200200558 · Cited by 41
FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes
Ono, M., Wada, Y., Wu, Y., Nemori, R., Jinbo, Y., Wang, H., Lo, K.-M., Yamaguchi, N., Brunkhorst, B. A., Otomo, H., et al. (1997) · Nature Biotechnology · doi:10.1038/nbt0497-343 · Cited by 40
Effects of diverse ω-conopeptides on the in vivo release of glutamic and γ-aminobutyric acids
Newcomb, R., & Palma, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90637-8 · Cited by 38
Horwell, D. C., Howson, W., Ratcliffe, G. S., et al. (1996) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(95)00169-7 · Cited by 38
Functional diversity of compound libraries
Gorse, A., & Lahana, R. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00091-0 · Cited by 37
How can enzymes be so efficient?
Williams, D. H., Stephens, E., & Zhou, M. (2003) · Chemical Communications · doi:10.1039/b305544m · Cited by 35
Chin, J. W., Grotzfeld, R. M., Fabian, M. A., & Schepartz, A. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00139-1 · Cited by 34
Boger, D. L. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00031-2 · Cited by 34
Boger, D. L., Desharnais, J., & Capps, K. (2003) · Angewandte Chemie · doi:10.1002/ange.200300574 · Cited by 33
Synthesis of charybdotoxin and of two N‐terminal truncated analogues
Vita, C., Bontems, F., Bouet, F., Tauc, M., Poujeol, P., Vatanpour, H., Harvey, A. L., Ménèz, A., & Toma, F. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18231.x · Cited by 32
Pei, Z., Xin, Z., Liu, G., Li, Y., Reilly, E. B., Lubbers, N. L., Huth, J. R., Link, J. T., von Geldern, T. W., Cox, B. F., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010059w · Cited by 28
The Bis-Azo Compound FP-21399 Inhibits HIV-1 Replication by Preventing Viral Entry
Zhang, J. L., Choe, H., Dezube, B. J., Farzan, M., Sharma, P. L., Zhou, X. C., Chen, L. B., Ono, M., Gillies, S. D., Wu, Y., et al. (1998) · Virology · doi:10.1006/viro.1998.9115 · Cited by 23
Design, synthesis, and evaluation of azepine-based cryptophycin mimetics
Smith, A. B., Cho, Y. S., Pettit, G. R., & Hirschmann, R. F. (2003) · Tetrahedron · doi:10.1016/s0040-4020(03)00857-3 · Cited by 22
In silico identification of functional protein interfaces
Bell, R. E., & Ben‐Tal, N. (2003) · Comparative and Functional Genomics · doi:10.1002/cfg.309 · Cited by 21
A Fly with an Ointment: Bcl-2 as an Anti-Mutator in Humans
Gottlieb, E. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.40 · Cited by 20
Design, Synthesis, and Evaluation of a Pyrrolinone-Based Matrix Metalloprotease Inhibitor
Smith, A. B., Nittoli, T., Sprengeler, P. A., Duan, J. J. ‐., Liu, R., & Hirschmann, R. F. (2000) · Organic Letters · doi:10.1021/ol000254p · Cited by 11
Cited by
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 716
Aromatic Amide Foldamers: Structures, Properties, and Functions
Zhang, D.-W., Zhao, X., Hou, J.-L., & Li, Z.-T. (2012) · Chemical Reviews · doi:10.1021/cr300116k · Cited by 690
BCL-2 family antagonists for cancer therapy
Lessene, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 621
Metadata
- Authors
- Yin, H., & Hamilton, A. D.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2005-06-23
- Volume
- 44
- Issue
- 27
- Pages
- 4130-4163
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2154382529
- Cited by
- 453
- References
- 296
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.